In the field of medicinal products decisions are taken both at the central level (marketing-price and reimbursement) and at regional level (PDTA) following processes involving Pharmaceutical Companies, Committees and other SSN dedicated bodies.
In-depth knowledge of how decisions are taken and the ability to monitor decision-making are  important for transparency reasons and for the quality and sharing of the decisions.In participatory laboratory mode, concrete cases of decision making will be simulated from its preparation, activation, evaluation, negotiation, and outcome management.

If you want to agree on a specific time for the meeting, please contact Dr. Elisa Cappelli



Comments are closed for this post.